Plaque psoriasis is more than just a skin condition. "It's a systemic inflammatory disease that starts inside the body and ...

Vulgaris is the Latin word for “common.” Plaque psoriasis on your feet causes similar symptoms as when it develops on other parts of your body. It’s characterized by raised patches of dry ...

Apremilast improves disease severity and patient-reported outcomes among adults with psoriasis, regardless of genital involvement.

If your child is taking Otezla to treat moderate to severe plaque psoriasis, their doctor will likely monitor their growth for unexpected changes. This will include their body weight and height.

Discover a study that investigates spesolimab, a monoclonal antibody that has been approved as the first GPP-specific therapy ...

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear skin, according to an interim analysis of a phase 3 trial.

Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICONIC-LEAD study Topline results from ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

specifically in terms of preventing body progression over time." Therapies targeting IL-23 have demonstrated good efficacy for moderate/severe plaque psoriasis and have become a treatment staple ...

Topline results from Phase 3 ICONIC-ADVANCE 1&2�studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe plaque PsO ...

These data add to the large body of evidence that highlights the ... ZORYVE cream, 0.3%, is indicated for topical treatment of plaque psoriasis, including intertriginous areas, in adult and ...